Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial
Titel:
Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial
Auteur:
Almskog, Lou M. Sjöström, Anna Sundén-Cullberg, Jonas Taxiarchis, Apostolos Ågren, Anna Freyland, Sara Börjesson, Madeleine Wikman, Agneta Wahlgren, Carl Magnus Wanecek, Michael van der Linden, Jan Antovic, Jovan Lampa, Jon Magnusson, Maria